Have a feature idea you'd love to see implemented? Let us know!

VTVT vTv Therapeutics Inc

Price (delayed)

$14.83

Market cap

$47.3M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.17

Enterprise value

$5.94M

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing oral, small molecule drug candidates. vTv has a pipeline of clinical drug candidates led by programs for the treatment ...

Highlights
VTVT's debt has dropped by 75% year-on-year and by 17% since the previous quarter
The company's EPS has surged by 58% YoY and by 36% QoQ
VTVT's equity has soared by 159% year-on-year but it is down by 9% since the previous quarter

Key stats

What are the main financial stats of VTVT
Market
Shares outstanding
3.19M
Market cap
$47.3M
Enterprise value
$5.94M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.97
Price to sales (P/S)
44.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.94
Earnings
Revenue
$1M
EBIT
-$18.2M
EBITDA
-$18.11M
Free cash flow
-$23.4M
Per share
EPS
-$4.17
Free cash flow per share
-$7.77
Book value per share
$4.99
Revenue per share
$0.33
TBVPS
$14.34
Balance sheet
Total assets
$43.16M
Total liabilities
$25.25M
Debt
$213,000
Equity
$15.01M
Working capital
$36.53M
Liquidity
Debt to equity
0.01
Current ratio
6.69
Quick ratio
6.51
Net debt/EBITDA
2.28
Margins
EBITDA margin
-1,810.9%
Gross margin
100%
Net margin
-1,830.6%
Operating margin
-2,362.9%
Efficiency
Return on assets
-47.3%
Return on equity
-265.3%
Return on invested capital
N/A
Return on capital employed
-49.5%
Return on sales
-1,819.9%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

VTVT stock price

How has the vTv Therapeutics stock price performed over time
Intraday
-4.08%
1 week
-5.19%
1 month
5.93%
1 year
41.37%
YTD
28.96%
QTD
9.33%

Financial performance

How have vTv Therapeutics's revenue and profit performed over time
Revenue
$1M
Gross profit
$1M
Operating income
-$23.63M
Net income
-$18.31M
Gross margin
100%
Net margin
-1,830.6%
The operating margin has soared by 99% YoY but it has contracted by 6% from the previous quarter
VTVT's net margin has surged by 99% year-on-year and by 9% since the previous quarter
The net income is up by 15% year-on-year and by 9% since the previous quarter
VTVT's operating income is up by 8% YoY but it is down by 6% QoQ

Growth

What is vTv Therapeutics's growth rate over time

Valuation

What is vTv Therapeutics stock price valuation
P/E
N/A
P/B
2.97
P/S
44.64
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.94
The company's EPS has surged by 58% YoY and by 36% QoQ
VTVT's equity has soared by 159% year-on-year but it is down by 9% since the previous quarter
The P/S is 97% lower than the 5-year quarterly average of 1667.5

Efficiency

How efficient is vTv Therapeutics business performance
The company's return on sales has surged by 99% YoY and by 9% QoQ
vTv Therapeutics's return on assets has increased by 45% YoY and by 26% QoQ

Dividends

What is VTVT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VTVT.

Financial health

How did vTv Therapeutics financials performed over time
VTVT's total assets is 71% greater than its total liabilities
VTVT's total assets has soared by 189% year-on-year but it is down by 7% since the previous quarter
The total liabilities has contracted by 14% YoY and by 3% from the previous quarter
VTVT's debt is 99% smaller than its equity
VTVT's equity has soared by 159% year-on-year but it is down by 9% since the previous quarter
The debt to equity has soared by 133% year-on-year but it has dropped by 50% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.